IBDEI1QL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30719,1,3,0)
 ;;=3^Acquired absence of cervix with remaining uterus
 ;;^UTILITY(U,$J,358.3,30719,1,4,0)
 ;;=4^Z90.712
 ;;^UTILITY(U,$J,358.3,30719,2)
 ;;=^5063593
 ;;^UTILITY(U,$J,358.3,30720,0)
 ;;=Z46.89^^178^1924^54
 ;;^UTILITY(U,$J,358.3,30720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30720,1,3,0)
 ;;=3^Fitting/Adjustment of Oth Devices
 ;;^UTILITY(U,$J,358.3,30720,1,4,0)
 ;;=4^Z46.89
 ;;^UTILITY(U,$J,358.3,30720,2)
 ;;=^5063023
 ;;^UTILITY(U,$J,358.3,30721,0)
 ;;=Z08.^^178^1924^50
 ;;^UTILITY(U,$J,358.3,30721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30721,1,3,0)
 ;;=3^F/U exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,30721,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,30721,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,30722,0)
 ;;=Z32.00^^178^1924^84
 ;;^UTILITY(U,$J,358.3,30722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30722,1,3,0)
 ;;=3^Pregnancy Test,Result Unknown
 ;;^UTILITY(U,$J,358.3,30722,1,4,0)
 ;;=4^Z32.00
 ;;^UTILITY(U,$J,358.3,30722,2)
 ;;=^5062848
 ;;^UTILITY(U,$J,358.3,30723,0)
 ;;=Z12.39^^178^1924^90
 ;;^UTILITY(U,$J,358.3,30723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30723,1,3,0)
 ;;=3^Screen for Malig Neop Breast
 ;;^UTILITY(U,$J,358.3,30723,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,30723,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,30724,0)
 ;;=Z12.31^^178^1924^67
 ;;^UTILITY(U,$J,358.3,30724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30724,1,3,0)
 ;;=3^Mammogram Screen for Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,30724,1,4,0)
 ;;=4^Z12.31
 ;;^UTILITY(U,$J,358.3,30724,2)
 ;;=^5062685
 ;;^UTILITY(U,$J,358.3,30725,0)
 ;;=Z12.4^^178^1924^91
 ;;^UTILITY(U,$J,358.3,30725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30725,1,3,0)
 ;;=3^Screen for Malig Neop Cervix
 ;;^UTILITY(U,$J,358.3,30725,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,30725,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,30726,0)
 ;;=N39.0^^178^1925^7
 ;;^UTILITY(U,$J,358.3,30726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30726,1,3,0)
 ;;=3^Urinary tract infection, site not specified
 ;;^UTILITY(U,$J,358.3,30726,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,30726,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,30727,0)
 ;;=R31.9^^178^1925^2
 ;;^UTILITY(U,$J,358.3,30727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30727,1,3,0)
 ;;=3^Hematuria, unspecified
 ;;^UTILITY(U,$J,358.3,30727,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,30727,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,30728,0)
 ;;=R31.0^^178^1925^1
 ;;^UTILITY(U,$J,358.3,30728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30728,1,3,0)
 ;;=3^Gross hematuria
 ;;^UTILITY(U,$J,358.3,30728,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,30728,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,30729,0)
 ;;=R31.2^^178^1925^3
 ;;^UTILITY(U,$J,358.3,30729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30729,1,3,0)
 ;;=3^Microscopic Hematuria NEC
 ;;^UTILITY(U,$J,358.3,30729,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,30729,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,30730,0)
 ;;=N39.3^^178^1925^5
 ;;^UTILITY(U,$J,358.3,30730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30730,1,3,0)
 ;;=3^Stress incontinence (female) (male)
 ;;^UTILITY(U,$J,358.3,30730,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,30730,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,30731,0)
 ;;=N39.41^^178^1925^6
 ;;^UTILITY(U,$J,358.3,30731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30731,1,3,0)
 ;;=3^Urge incontinence
 ;;^UTILITY(U,$J,358.3,30731,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,30731,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,30732,0)
 ;;=N39.46^^178^1925^4
 ;;^UTILITY(U,$J,358.3,30732,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1QL
